TNFR Pathway-Related Proteins and Recurrent Coronary Artery Disease Events

Jiwoo Lee1, Tiffany R Bellomo2, Jennifer L Halford3

  • 1Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.

JACC. Advances
|March 21, 2026
PubMed

Insights

Coronary artery disease (CAD) complications persist despite treatments. This study identified 102 proteins linked to recurrent CAD events, emphasizing tumor necrosis factor receptor (TNFR) pathway involvement.

Area of Science:

  • Cardiovascular Research
  • Proteomics
  • Immunology

Background:

  • Coronary artery disease (CAD) remains a leading global cause of mortality.
  • Existing treatments and lifestyle modifications do not fully mitigate CAD complications.
  • Understanding residual risk factors is crucial for improving patient outcomes.

Purpose of the Study:

  • To identify specific proteins and molecular pathways associated with recurrent CAD events.
  • To elucidate the underlying mechanisms contributing to residual risk in CAD patients.
  • To uncover potential therapeutic targets for managing CAD progression.

Main Methods:

  • Utilized UK Biobank data from 1,009 participants with baseline proteomic measures and CAD.
  • Employed Olink plasma proteomic analysis to measure 1,463 proteins.
  • Applied Cox proportional hazards regression to model associations between proteins and recurrent CAD events.

Main Results:

  • 102 out of 1,463 proteins were independently associated with recurrent CAD events.
  • Tumor necrosis factor receptor (TNFR) activity was significantly enriched (100-fold enrichment).
  • Specific proteins like tumor necrosis factor-alpha, TNFR1, and TNFR2 showed significant associations with increased risk of recurrent CAD.

Conclusions:

  • The study highlights the complex role of TNFR1 and TNFR2 pathways in CAD progression.
  • Findings suggest inflammation-related targets within the TNFR pathway are critical for therapeutic strategies.
  • Further research is needed to translate these proteomic findings into clinical interventions for CAD.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
937
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
730
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
684
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
395
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
409